‘Palbociclib’ approved by the US Food and Drug Administration (FDA) for breast cancer

By: Agencies | | Updated: February 23, 2015 11:33 am

Washington, Feb 23: A new drug that works by blocking molecules responsible for cancer cell growth has been found to be effective for advanced breast cancer patients. The drug called palbociclib, an investigational oral medication, has been found to be well tolerated and extends progression-free survival (PFS) in newly diagnosed cancer. The palbociclib was recently approved by the US Food and Drug Administration (FDA) for metastatic breast cancer patients just beginning to undergo endocrine therapy. (Read: Mammography screening can reduce breast cancer deaths: Study)

The FDA approval has expanded treatments options for many metastatic breast cancer patients, but these new results are showing how effective the drug can also be for breast cancer patients who have already tried endocrine therapies and may be running out of options, said Angela DeMichele from Perelman School of Medicine at University of Pennsylvania. The drug was developed by researchers at Penn Medicine. (Read: 10 questions you should ask your doctor after you have been diagnosed with breast cancer)

Patients enrolled in the trial had previously undergone several prior chemotherapy and hormonal regimen for metastatic disease. The drug was extremely well-tolerated in this trial, and the absence of symptoms commonly associated with cancer treatment, such as nausea, diarrhoea, or pain was remarkable, said professor Peter O’Dwyer at Perelman School of Medicine at University of Pennsylvania. (Read: Being diagnosed with breast cancer is not a death sentence)

The palbociclib drug may be effective in other types of cancer that operate by a similar mechanism. These trials are currently ongoing, said Amy Clark, from Perelman School of Medicine at University of Pennsylvania. The results appeared in Clinical Cancer Research. (Read: Gene responsible for the worst type of breast cancer identified)

Source: IANS

Photo source: Getty images

Published : February 23, 2015 11:29 am | Updated:February 23, 2015 11:33 am

Read Disclaimer

The Oscars 2015 -- Eddie Redmayne wins Best Actor for playing Stephen Hawking with MND in 'The Theory of Everything'

20 positive cases, no new swine flu case in Himachal: Official

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

We respect your privacy

The Oscars 2015 -- Eddie Redmayne wins Best Actor for playing Stephen Hawking with MND in 'The Theory of Everything'

20 positive cases, no new swine flu case in Himachal: Official

Breathing extra oxygen spurts growth of tumour-fighting cells, improves cancer treatment

Cancer growth can now be slowed

Kerala assembly Speaker critical, undergoing treatment for cancer

Singapore PM back at work after surgery for prostate cancer

Former NBC anchor, Tom Brokaw's memoir on 'battle against cancer' out in May

About The health Site

Useful Links